Abstract
Development of the T cell lineage is characterized by the homing of hematopoietic precursors to thymus, followed by their acquisition of receptors for antigen. T cell receptors are alpha beta or gamma delta heterodimers associated with CD3 (TCR-CD3). Very early T cell precursors in humans have been characterized as CD7+ 45+ cells which lack the T cell differentiation antigens CD1, CD2, CD3, CD4, and CD8. A phenotypically equivalent early thymocyte population also occurs in postnatal life, and we have previously shown that interleukin 2 (IL2) promotes the development in vitro of both the alpha beta and the gamma delta T cells from these early thymocytes. Here we have analyzed the requirements of the induction of the IL2 pathway in early thymocytes, and their developmental potential. We show that: (i) thymic stromal cells, which are present in thymocyte suspensions, are necessary to induce the IL2 pathway and the development of alpha beta or gamma delta T cell lineages from early thymocytes in vitro; and (ii) when removed from the in vivo environment, early thymocytes can develop in vitro into TCR-CD3- cells of the natural killer (NK) lineage. We conclude that CD7+ 45+, CD1-2-3-4-8- early thymocytes are multipotential progenitors...Continue Reading
Citations
Sep 1, 1992·Journal of Clinical Immunology·T S Barry, B F Haynes
May 1, 1994·Immunology Letters·L MorettaA Moretta
Sep 1, 1993·Immunology Today·R L BoydP Hugo
May 18, 2001·Developmental and Comparative Immunology·T ZhaoS J Mentzer
Feb 1, 1994·Research in Immunology·H SpitsA Galy
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·V GrohJ L Strominger
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BárcenaC Martínez-A
Jun 1, 1993·The Journal of Experimental Medicine·G E TjønnfjordT Egeland
Jul 1, 1993·The Journal of Experimental Medicine·D L KraftE K Waller
Aug 1, 1993·The Journal of Experimental Medicine·A GalyH Spits
Dec 1, 1993·The Journal of Experimental Medicine·M J SánchezJ H Phillips
Nov 5, 2003·Journal of Hematotherapy & Stem Cell Research·Øystein Wendelbo, Øystein Bruserud
Jul 31, 2013·PloS One·Antonio LapennaRichard Aspinall
Dec 1, 2001·Expert Opinion on Biological Therapy·Ø Bruserud, Ø Wendelboe
Jul 1, 1991·Immunology Today·G Kroemer, C Martínez
Feb 1, 1991·Immunology Today·R L Boyd, P Hugo
Jun 1, 1995·Seminars in Immunology·B Péault
Sep 1, 1991·The Journal of Pediatrics·L SanchoM Alvarez-Mon
Jan 1, 1991·European Journal of Immunology·A González-FernándezF Gambón Deza
Jan 1, 1994·International Journal of Clinical & Laboratory Research·L MorettaA Moretta
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marek SinkoraWolfgang Holtmeier
Jan 1, 1995·European Journal of Haematology·G E TjønnfjordT Egeland